![]() |
|||||||||||
Sex Differences in Early Brain Development; Brain Development in Turner Syndrome
This study is currenly Recruiting patients.
Sponsored by:
University of North Carolina, Chapel Hill
Purpose
Relative risk for many psychiatric disorders differs dramatically in males and females.
Early-onset disorders, such as autism, occur more often in males; other conditions, such as
schizophrenia, occur at similar rates in males and females, but the sexes differ in
expression. It has been hypothesized that the prevalence and expression of these disorders
is related to sex differences in brain development. X-chromosome effects and early exposure
to gonadal hormones are strong candidates for a causal role. The aims of the research are
(1) to characterize sex differences in brain development from birth to age 2; (2) to test
whether brain development is altered in infants with Turner syndrome, a well-defined genetic
disorder resulting from the partial or complete loss of one of the sex chromosomes. To
address aim 1, high resolution MRI, including diffusion tensor imaging (DTI), will be used
to characterize sex differences in brain development from birth to age 2 in a longitudinal
cohort of 250 children. To address aim 2, high resolution MRI, including DTI, will be used
to compare brain development in 30 infants with Turner syndrome (X monosomy) to 30 matched
controls. The investigators hypothesize that sex differences in gray and white matter
development and in white matter maturation as assessed by DTI will be present during the
first 2 years of life and that children with TS will exhibit abnormal gray and white matter
development in the neonatal period.
Study Type: Treatment
Study Design:Observational Model: Case Control, Time Perspective: Prospective
Official Title: Sex Differences in Early Brain Development; Brain Development in Turner Syndrome
Further Study Details:
Expected Total Enrollment:
Study Dates:October 2006 -
Eligibility
Ages Eligible for Study- Min: N/A Max: 2 Years
Gender: Both
Criteria
Inclusion Criteria: the absence of major medical or psychiatric conditions in the mother. testing. Exclusion Criteria: medical problems or congenital conditions in the child. i.e. metal in the body)
Location and Contact Information
Please refer to this study by ClinicalTrials.gov identifier: NCT00877942
North Carolina
University of North Carolina at Chapel Hill - Chapel Hill, North Carolina 27599
Rebecca C Knickmeyer, Ph.D. 919-966-2216 rebecca_knickmeyer@med.unc.edu
More Information
Record Last Reviewed:February 2010
Last Updated:February 2, 2010
Record First Recieved:April 6, 2009
ClinicalTrials.gov Identifier:NCT00877942
Health Authority: United States Food and Drug Administration
Information obtained from ClinicalTrials.gov on September 02, 2010
|
|
||||||||||